Choolip & Sciences Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
43
- Stock Symbol
-
291650
- Investments
-
4
- Share Price
-
$1.67
- (As of Friday Closing)
Choolip & Sciences General Information
Description
Choolip & Sciences inc is a biotechnology company engaged in the development of aptamer-based therapeutics and diagnostic technologies. Its platform develops aptamer-drug conjugates (ApDCs) and chimeric aptamers by combining various functional drug types, ranging from small molecule drugs to biomolecules (antibodies, nucleic acids), into aptamer molecules.
Contact Information
Website
www.choolipscience.comCorporate Office
- Room 301, Building 3, 15, Pangyo-ro 228beon-gil, Bundang-gu
- Sampyeong-dong, Pangyo 7 Venture Valley 1
- Seongnam-si, Gyeonggi 13487
- South Korea
Corporate Office
- Room 301, Building 3, 15, Pangyo-ro 228beon-gil, Bundang-gu
- Sampyeong-dong, Pangyo 7 Venture Valley 1
- Seongnam-si, Gyeonggi 13487
- South Korea
Choolip & Sciences Timeline
Choolip & Sciences Stock Performance
As of 13-Nov-2026, Choolip & Sciences’s stock price is $1.67. Its current market cap is $51.1M with 30.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.67 | $1.66 | $0.87 - $2.66 | $51.1M | 30.5M | 49.2K | -$0.36 |
Choolip & Sciences Financials Summary
As of 31-Mar-2026, Choolip & Sciences has a trailing 12-month revenue of $2.54M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 41,425 | 7,757 | 17,725 | 32,859 |
| Revenue | 2,537 | 2,463 | 794 | 186 |
| EBITDA | (5,240) | (5,304) | (5,200) | (9,742) |
| Net Income | (6,173) | (6,058) | (6,378) | (10,403) |
| Total Assets | 30,257 | 28,545 | 21,712 | 25,247 |
| Total Debt | 7,905 | 5,252 | 1,347 | 6,426 |
Choolip & Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Choolip & Sciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Choolip & Sciences Patents
Choolip & Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025143775-A1 | Branched enzyme-cleavable linker-payload and method for efficiently producing same | Inactive | 26-Dec-2023 | ||
| EP-4729617-A1 | Aptamer targeting cd25, drug conjugate comprising same, and use thereof | Pending | 16-Jun-2023 | ||
| WO-2024257962-A1 | Aptamer targeting cd25, drug conjugate comprising same, and use thereof | Inactive | 16-Jun-2023 | ||
| WO-2024186176-A1 | Method for preparing modified nucleosides from thymidine | Inactive | 09-Mar-2023 | ||
| WO-2023177246-A1 | Egfrviii-specific aptamer and uses thereof | Inactive | 18-Mar-2022 | C12N15/115 |
Choolip & Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Choolip & Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Choolip & Sciences Investments & Acquisitions (4)
Choolip & Sciences’s most recent deal was a Merger/Acquisition with Choolip for . The deal was made on 10-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Choolip | 10-Apr-2026 | Merger/Acquisition | Other Consumer Non-Durables | ||
| Focus AI (Computers, Parts and Peripherals) | 10-Feb-2026 | PIPE | Computers, Parts and Peripherals | ||
| International Scientific Standard | 19-Aug-2024 | Merger/Acquisition | Drug Discovery | ||
| BL Science (276.53 Square Meters of Land and Building Property in Seongnam, South Korea) | 21-Jun-2021 | Corporate Asset Purchase | Buildings and Property |
Choolip & Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Choolip & Sciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Choolip | Torrance, CA |
Choolip & Sciences FAQs
-
When was Choolip & Sciences founded?
Choolip & Sciences was founded in 2011.
-
Where is Choolip & Sciences headquartered?
Choolip & Sciences is headquartered in Seongnam-si, South Korea.
-
What is the size of Choolip & Sciences?
Choolip & Sciences has 43 total employees.
-
What industry is Choolip & Sciences in?
Choolip & Sciences’s primary industry is Drug Discovery.
-
Is Choolip & Sciences a private or public company?
Choolip & Sciences is a Public company.
-
What is Choolip & Sciences’s stock symbol?
The ticker symbol for Choolip & Sciences is 291650.
-
What is the current stock price of Choolip & Sciences?
As of 13-Nov-2026 the stock price of Choolip & Sciences is $1.67.
-
What is the current market cap of Choolip & Sciences?
The current market capitalization of Choolip & Sciences is $51.1M.
-
What is Choolip & Sciences’s current revenue?
The trailing twelve month revenue for Choolip & Sciences is $2.54M.
-
What is Choolip & Sciences’s annual earnings per share (EPS)?
Choolip & Sciences’s EPS for 12 months was -$0.36.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
